Journal article
A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose
Abstract
The introduction of new factor concentrates has, at times, resulted in an increase in inhibitor development; hence large systematic surveys of inhibitor development are necessary whenever new products are introduced. This study presents the results of a surveillance study conducted by the Inhibitor Subcommittee of the Association of Hemophilia Clinic Directors of Canada that evaluated inhibitor development in patients with haemophilia A …
Authors
RUBINGER M; LILLICRAP D; RIVARD GE; TEITEL J; CARCAO M; HENSMAN C; WALKER I; DIRECTORS OF CANADA TAOHC
Journal
Haemophilia, Vol. 14, No. 2, pp. 281–286
Publisher
Wiley
Publication Date
March 2008
DOI
10.1111/j.1365-2516.2007.01634.x
ISSN
1351-8216